CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,338,000 | -16.3% | 54,000 | +23.0% | 0.16% | +390.6% |
| Q4 2021 | $1,598,000 | -76.3% | 43,900 | -88.8% | 0.03% | -84.3% |
| Q3 2021 | $6,732,000 | +14.4% | 393,700 | -10.5% | 0.20% | -2.4% |
| Q2 2021 | $5,887,000 | +572.0% | 439,700 | +2471.3% | 0.21% | +895.2% |
| Q1 2021 | $876,000 | -58.4% | 17,100 | -49.7% | 0.02% | -47.5% |
| Q4 2020 | $2,106,000 | -72.1% | 34,000 | -75.3% | 0.04% | -85.7% |
| Q3 2020 | $7,540,000 | +261.6% | 137,600 | +279.8% | 0.28% | +93.1% |
| Q2 2020 | $2,085,000 | – | 36,230 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
| Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
| Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
| Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
| Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
| Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
| Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
| Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
| Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |